跳到主要內容
Quest Diagnostics Home.

出血和血栓形成

Laboratory blood testing, together with a patient exam and medical history, is vital to correctly diagnosing bleeding and/or thrombotic disorders. Quest Diagnostics has a large, highly advanced test menu for these blood conditions.

\r\n

Tests for bleeding disorders and thrombosis serve many functions, most notably detecting hemostasis defects and thrombosis risk, monitoring anticoagulant therapy, evaluating thrombotic conditions, and investigating the cause of abnormal PT and aPTT test results. Quest testing can be enhanced with consultative reports, interpretations, FAQs, and expert insight.

\r\n","@type":"corporate/components/text"}}" id="text-cdc250b794" class="cmp-text">

實驗室血液測試與患者考試和病史以及正確診斷出血和/或血栓形成疾病至關重要。Quest Diagnostics對這些血液條件具有大型高度高級的測試菜單。

出血性疾病和血栓形成的測試服務許多功能,最顯著的檢測止血缺陷和血栓形成風險,監測抗凝血治療,評估血栓形成條件,並研究異常PT和APTT測試結果的原因。Quest測試可以通過協商報告,解釋,常見問題解答和專家洞察力來加強。

covid-19和凝血病

患有SARS-COV-2(Covid-19)感染的患者中血凝塊,中風,心髒病發作和器官失敗的患者患病率很高的證據。1考慮監測血小板計數,pt / aptt,d-二聚體和纖維蛋白原。延長預防患者提出了對患者的持續監測患者。2

看視頻

測試產品組合

\r\n
  • Bleeding profiles and screening tests
  • \r\n
  • von Willebrand disease
  • \r\n
  • Factor assays and inhibitors
  • \r\n
  • Anticoagulant therapy
  • \r\n
  • HIT, TTP, and platelet studies
  • \r\n
  • Fibrinolysis and markers of thrombin generation
  • \r\n
  • Thrombotic risk markers and profiles–inherited
  • \r\n
  • Antiphospholipid antibody and lupus anticoagulant
  • \r\n
  • Women’s health
  • \r\n
  • D-Dimer: D-Dimer is one of the measurable by-products of activation of the fibrinolytic system. Quantitation of D-Dimer assesses fibrinolytic activation and intravascular thrombosis. D-Dimer is of particular value in excluding the diagnosis of venous thromboembolism among patients at high risk.
  • \r\n\r\n","@type":"corporate/components/text"}}" id="text-035962b3ca" class="cmp-text">
    • 出血簡檔和篩選測試
    • von willebrand病
    • 因子測定和抑製劑
    • 抗凝血治療
    • 點擊,TTP和血小板研究
    • 凝血酶產生的纖維蛋白溶解和標記
    • 血栓性風險標記和概況概況
    • 抗磷脂抗體和狼瘡抗凝血劑
    • 女性健康
    • D-二聚體:D-二聚體是纖維蛋白溶解係統的可測量副產物之一。D-二聚體的定量評估纖維蛋白溶解活化和血管內血栓形成。D-DIMER特別有價值,不包括高風險患者靜脈血栓栓塞的診斷。

    任務的力量

    參考

    1. varga z,flammer aj,steiger p等人。Covid-19中內皮細胞感染和內皮炎。蘭蔻。2020; 395(10234):1417-1418。DOI:10.1016 / s0140-6736(20)30937-5

    2. Bikdeli B,Madhavan MV,Jimenez D等人。Covid-19和血栓形成或血栓栓塞疾病:預防,抗血栓治療和隨訪的影響:Jacc最先進的審查。J am Coll Cardiol。2020; 75(23):2950-2973。DOI:10.1016 / J.JACC.2020.04.031


    此信息僅供參與信息,並非作為醫療建議。醫生的考試選擇和解釋,診斷和患者管理決策應基於他/她的教育,臨床專業知識和患者的評估。

    Resources\r\n

    Clinical expert consultation

    \r\n","@type":"corporate/components/text"}}" id="text-15df356ce6" class="cmp-text">
    資源

    臨床專家谘詢

    Baidu
    map